
Rachel Issaka, MD, MAS: Effective CRC Prevention Programs Require Multispecialty Commitment
ACP 2025. A focused CRC prevention program begins with primary care where support and advocacy for regular screening begins, Issaka stressed.
Effective
Issaka, associate professor of medicine and the Kathryn Surace-Smith endowed chair in health equity research at Fred Hutchinson Cancer Center, spoke with Patient Care© following her presentation and highlighted the integral role in the patient's journey of the frontline primary care clinicians, who advocate for regular screening, gastroenterologists, who provide guidance in the event of an abnormal finding, and oncologists, who manage treatment of disease. She also noted the contributions of an IT team to ensure the timely and consistent flow of information that will support identification of patients who are eligible for CRC screening.
Representation of all stakeholders is one key to the success of a program but methodical documentation is essential, Issaka said, to ensure the correct population is addressed and that there is meticulous follow-through for all patients who are identified.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.










































































































































































































































































































